Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004396 · ClinicalTrials.gov registry record · Phase 2
Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias
A Phase 2 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 2
- Development phase
- 32
- Enrollment target
NCT00004396 is a Phase 2 study that has completed, run by National Center for Research Resources (NCRR). The registered enrollment target is 32 participants.
The verdict
NCT00004396, a Phase 2 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 32 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Compare the efficacy of heme arginate, singly or in combination with tin mesoporphyrin, in lowering porphyrin precursors in patients with asymptomatic acute intermittent porphyria. II. Evaluate and compare the safety and tolerability of these treatment regimens in this patient population.
Interventions
- DRUG tin mesoporphyrin
- DRUG heme arginate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 1997-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004396
The ClinicalTrials.gov registry entry for NCT00004396 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which tin mesoporphyrin is the first listed.
NCT00004396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004396 about?
NCT00004396 is a clinical study titled "Studies in Porphyria III: Heme and Tin Mesoporphyrin in Acute Porphyrias". OBJECTIVES: I. Compare the efficacy of heme arginate, singly or in combination with tin mesoporphyrin, in lowering porphyrin precursors in patients with asymptomatic acute intermittent porphyria. II. Evaluate and compare the safety and tolerability of these treatment regimens in this patient popula...
What is the current status of trial NCT00004396?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 32 participants. The study started on 1997-09.
What interventions are being tested in trial NCT00004396?
The interventions under investigation include: tin mesoporphyrin (DRUG), heme arginate (DRUG).
Who is sponsoring clinical trial NCT00004396?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.